The Middle East and Africa Gene Expression Analysis Market was worth USD 0.37 Billion in 2018 and is projected to grow at a CAGR of 7.53%, to reach USD 0.54 Billion by 2023. A gene produces a functional product which is generally protein with the help of the instructions it contains. This process is called gene expression. The process includes different steps namely transcription and translation using transfer, ribosomal and messenger RNAs.
Cells can alter their gene expression to enhance or reduce the production of a protein depending upon the environment and available resources. By observing these triggers for gene regulation, drugs can be designed to externally initiate the regulations according to the need. This study has the potential to revolutionize medicine and healthcare fields.
Applications of gene expression analysis in advanced drug development, increasing research activities on gene expression profiling and declining prices of gene sequencing are the major factors driving the growth of the gene expression analysis market. Lack of proper awareness and unaffordable costs of instruments used for gene expression analysis are restraining the growth rate of market.
The Middle East and Africa gene expression analysis market is segregated on the basis of Consumables, Technology, Applications, Services and region. On the basis of Consumables, the market is segregated into DNA chips and Reagents. On the basis of Technology, the market is segregated into Polymerase Chain Reaction (PCR), Next Generation Sequencing, DNA Microarray, Serial Analysis of Gene Expression and Northern Blotting. SAGE segment is expected to be the fastest growing segment as it is one of the latest techniques that help in analyzing thousands of DNA transcripts at a time. On the basis of Applications, the market is segregated into Research, Drug discovery, diagnostics and other applications. Research holds the largest market share in this segment. Drug discovery and diagnostics are rapidly growing segments owing to the increasing focus on precision medicine. On the basis of Services, the market is segregated into gene expression profiling and bioinformatics solutions. The gene expression profiling services is again segregated into sequencing services and other services. Gene expression profiling holds the largest market share due to the rising number of gene expression analysis tests.
The gene expression analysis market in this region is analyzed under Middle East and Africa regions. The growth rate of the market is somewhat slow in this region due to the lack of economic support. However, with the involvement of private organizations from America and China, the market conditions have improved significantly.
Some of the major companies in the gene expression analysis market are Life Technologies, Thermo Fisher Scientific, Inc., Affymetrix, GE Healthcare, QIAGEN N.V., Agilent Technologies, PerkinElmer, Roche, Illumina, Inc., Oxford Gene Technology, Bio-Rad Laboratories, and Luminex Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Consumables
5.1.1 Introduction
5.1.2 DNA Chips
5.1.3 Reagents
5.1.4 Y-o-Y Growth Analysis, By Consumables
5.1.5 Market Attractiveness Analysis, By Consumables
5.1.6 Market Share Analysis, By Consumables
5.2 Technology
5.2.1 Introduction
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Dna Microarray
5.2.4 Serial Analysis Of Gene Expression
5.2.5 Northern Blotting
5.2.6 Next-Generation Sequencing (NGS)
5.2.6.1 Cost and Speed Of NGS
5.2.6.2 Research Laboratories and Academicians Promoting NGS
5.2.6.3 Substitution Of Microarray Technology By NGS
5.2.6.4 Global Alliances Among Leading Research Institutes to Assist Drug Discovery and Increase theDemand for NGS
5.2.7 Y-o-Y Growth Analysis, By Technology
5.2.8 Market Attractiveness Analysis, By Technology
5.2.9 Market Share Analysis, By Technology
5.3 Applications
5.3.1 Introduction
5.3.2 Research
5.3.3 Diagnostics
5.3.4 Drug Discovery
5.3.5 Other Applications
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 Services
5.4.1 Introduction
5.4.2 Gene Expression Profiling Services
5.4.2.1 Sequencing Services
5.4.2.2 Other Services
5.4.3 Bioinformatics Solutions
5.4.4 Y-o-Y Growth Analysis, By Services
5.4.5 Market Attractiveness Analysis, By Services
5.4.6 Market Share Analysis, By Services
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Consumables
6.1.3.3 By Technology
6.1.3.4 By Applications
6.1.3.5 By Services
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Consumables
6.1.4.3 By Technology
6.1.4.4 By Applications
6.1.4.5 By Services
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Consumables
6.1.5.3 By Technology
6.1.5.4 By Applications
6.1.5.5 By Services
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 QIAGEN N.V.
8.4 Life Technologies
8.5 Agilent Technologies
8.6 PerkinElmer
8.7 Bio-Rad Laboratories
8.8 Roche Diagnostics
8.9 Oxford Gene Technology
8.10 Luminex Corporation.
8.11 Affymetrix
8.12 Illumina, Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
